Para citar este trabalho use um dos padrões abaixo:
Antimicrobial resistance is a serious global concern health system, mainly in Klebsiella pneumoniae infections. K. pneumoniae resistance is a major challenge in medicine since it exhibits resistance to multiple antibiotics and it is associated with nosocomial infections, leading to many deaths each year. Antimicrobial resistance control strategies are needed to avoid the spread of resistant strains, not only in the hospital environment, but with focus on the One Health approach. The development of new therapies focused on eliminating the resistant bacteria or to assist antibiotics activities are needed. In that sense, this study investigated the effect of modulation of the A2B receptor in mice during pneumonia infection by K. pneumoniae. Previous studies have shown that A2B receptor deficiency improves host defense and survival in mice with K. pneumoniae pneumonia (Barletta et al., 2012), suggesting that modulation of this receptor could enhance antibiotic-mediated bacterial killing. For that, Swiss mice received intratracheal instillation of K. pneumoniae and, 6 hours after the infection, they were treated with 1 mg/kg or 5 mg/kg of PSB603, an antagonist of A2B receptor, intraperitoneally. Then, 24h after intratracheal instillation, mice were followed to observe the mortality rate or were euthanized (#L-024-2025). During euthanasia the bronchoalveolar fluid (BAL) was collected to evaluate the levels of cytokines, leukocytes levels, and observe the leukocyte profile in mice lungs. As results, we observed that animals treated with A2B antagonist showed a decrease in survival rate, and clinical score was higher in those groups. The levels of leukocytes in BAL were similar between groups, but animals treated with the higher doses of PSB603 showed an increase in polymorphonuclear cells. CFU in BAL were also quantified and the data showed an increasing tendency in animals that received PSB603 but no difference were observed in proinflammatory cytokine levels.
Com ~200 mil publicações revisadas por pesquisadores do mundo todo, o Galoá impulsiona cientistas na descoberta de pesquisas de ponta por meio de nossa plataforma indexada.
Confira nossos produtos e como podemos ajudá-lo a dar mais alcance para sua pesquisa:
Esse proceedings é identificado por um DOI , para usar em citações ou referências bibliográficas. Atenção: este não é um DOI para o jornal e, como tal, não pode ser usado em Lattes para identificar um trabalho específico.
Verifique o link "Como citar" na página do trabalho, para ver como citar corretamente o artigo